Floatz logo

Tadalafil

Priapism

Vanderbilt University Medical CenterSmall moleculePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Priapism cohort.

Asset / SponsorPhaseRating
Hydroxyurea
Vanderbilt University Medical Center
Phase 2B
Crizanlizumab
Novartis Pharmaceuticals
Phase 2B
Sildenafil
Johns Hopkins University
Phase 2B
TESTOSTERONE UNDECYLATE
Johns Hopkins University
Early Phase 1C

Same molecule, other indications

Tadalafil is also rated in:

sexual disorderDormant
BBB
Indicative ·
72 / 100
View asset →
erectile dysfunctionDormant
BB
Indicative ·
69 / 100
View asset →
Duchenne muscular dystrophyDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →